Publication | Closed Access

Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge

VaccinationNanomedicineNanoparticlesCross-protectionEngineeringVaccine DevelopmentLethal Influenza ChallengeImmunologyInfluenza VaccineSelf-adjuvanted Protein NanoparticlesVaccine DesignPolyvalent VaccineMedicineFlu VaccinationEgg-based Vaccine ProductionInfluenza Vaccines